SkinHealth Systems Inc. (SKIN) stock
SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30316% above fair value
$12.46−1.41 (-10.20%)
Close on Nov 18, 2026Market cap $1.62BP/E –Yield –
SkinHealth Systems operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
SkinHealth Systems's operating cash flow for the twelve months ending Jun 30, 2026 was $21.96M, down 44.3% year over year. For fiscal 2025 it was $37.49M, up 132.3% from the year before. The highest annual figure on record is $37.49M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.49M | +132.3% |
| FY2024 | Dec 31, 2024 | $16.13M | -25.8% |
| FY2023 | Dec 31, 2023 | $21.75M | – |
| FY2022 | Dec 31, 2022 | -$106.60M | – |
| FY2021 | Dec 31, 2021 | -$28.36M | – |
| FY2020 | Dec 31, 2020 | -$12.44M | -819.7% |
| FY2019 | Dec 31, 2019 | $1.73M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.67M | -72.3% |
| Q1 FY2026 | Mar 31, 2026 | -$5.55M | -285.4% |
| Q4 FY2025 | Dec 31, 2025 | $15.20M | -7.7% |
| Q3 FY2025 | Sep 30, 2025 | $9.65M | -6.5% |
| Q2 FY2025 | Jun 30, 2025 | $9.65M | +55.6% |
| Q1 FY2025 | Mar 31, 2025 | $3.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $16.47M | – |
| Q3 FY2024 | Sep 30, 2024 | $10.32M | -42.6% |
| Q2 FY2024 | Jun 30, 2024 | $6.20M | -71.8% |
| Q1 FY2024 | Mar 31, 2024 | -$16.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.17M | – |
| Q3 FY2023 | Sep 30, 2023 | $17.96M | – |
| Q2 FY2023 | Jun 30, 2023 | $21.97M | – |
| Q1 FY2023 | Mar 31, 2023 | -$13.01M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.39M | -264.5% |
| Q3 FY2022 | Sep 30, 2022 | -$31.40M | -10637.2% |
| Q2 FY2022 | Jun 30, 2022 | -$31.34M | – |
| Q1 FY2022 | Mar 31, 2022 | -$38.47M | -3150.8% |
| Q4 FY2021 | Dec 31, 2021 | $3.28M | – |
| Q3 FY2021 | Sep 30, 2021 | $298.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$33.20M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.26M | – |
| Q4 FY2020 | Dec 31, 2020 | -$411.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$540 | – |
See a number that looks wrong?